Decitabine enhances chemosensitivity of early T-cell precursor-acute lymphoblastic leukemia cell lines and patient-derived samples

Leuk Lymphoma. 2016 Aug;57(8):1938-41. doi: 10.3109/10428194.2015.1110747. Epub 2016 Jan 4.
No abstract available

Publication types

  • Letter

MeSH terms

  • Animals
  • Antineoplastic Agents / administration & dosage
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Combined Chemotherapy Protocols / pharmacology*
  • Azacitidine / administration & dosage
  • Azacitidine / analogs & derivatives*
  • Azacitidine / pharmacology
  • Basic Helix-Loop-Helix Transcription Factors / genetics
  • Cell Line, Tumor
  • Cell Survival / drug effects
  • Cell Survival / genetics
  • Decitabine
  • Drug Synergism
  • Gene Expression Regulation, Leukemic / drug effects
  • Humans
  • Jurkat Cells
  • Mice
  • Neoplasm Proteins / genetics
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / drug therapy*
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / genetics
  • Precursor T-Cell Lymphoblastic Leukemia-Lymphoma / pathology
  • Receptors, Interleukin-7 / genetics
  • Reverse Transcriptase Polymerase Chain Reaction
  • Xenograft Model Antitumor Assays*

Substances

  • Antineoplastic Agents
  • Basic Helix-Loop-Helix Transcription Factors
  • LYL1 protein, human
  • Neoplasm Proteins
  • Receptors, Interleukin-7
  • Decitabine
  • Azacitidine